Investors

image

Download our corporate presentation

image
image

Mereo BioPharma to host conference call to highlight positive topline results from ASTRAEUS a Phase 2 trial of alvelestat in alpha-1 antitrypsin deficiency-associated emphysema 

image

Investors News & Events

Subscribe to our email alerts

View our privacy notice

close

Subscribe

* indicates required
Alert Types

We respect your privacy and do not sell, rent or loan any identifiable information collected on this site. Any information that you give us will be treated with the utmost care and security and according to current data protection legislation. It will not be used in ways to which you have not consented. Please review our privacy policy before providing any information and select the YES option button to consent receiving the selected information.